Marianne De Backer

This profile gathers the share dealings of Marianne De Backer across 3 companies, led by Arrowhead Pharmaceuticals, Inc., Vir Biotechnology, Inc. and Kronos Bio, Inc. Over a trading history stretching from 1 January 2020 to 29 April 2026, the count stands at 30 filings.

The open-market side counts 13 purchases for €196k alongside 6 sales for €2.3M. Sales outweigh purchases by €2.1M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants. 2026 to date brings no purchases and 2 sales.

Half of the purchases are above €14k and half below. No cluster: in 13 purchases, no other insider of the company bought within 30 days.

Most recently, on 30 April 2026, the filings show a transaction in Vir Biotechnology, Inc. The last purchase on record was published on 2 December 2021, which is 1,784 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.